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We describe a nested polymerase chain reaction for
the identification of Borrelia species from serum of patients
with unidentified fevers. This technique, based on single
nucleotide polymorphisms of the 16S ribosomal RNA gene,
was used to test blood samples from 7,750 patients, 33 of
whom were diagnosed with spirochete infections. Borrelia
crocidurae was the only species identified. 
T
ickborne relapsing fevers, caused by spirochetes of the
genus  Borrelia, vary in severity and frequency of
recurrence. The prevalence of various Borrelia species
depends on the locality. In West Africa, Borrelia crocidu-
rae is the primary cause of relapsing fevers (1–3), although
B. duttonii and B. recurrentis are also found in Senegal.
Tickborne relapsing fever is difficult to diagnose and is
often confused in its early stages with malaria or relapsing
malaria. Diagnosis is routinely made by conventional
microscopy (Giemsa-stained thick blood smear) or fluo-
rescence microscopy after concentration of blood in capil-
lary tubes and staining with acridine orange (quantitative
buffy coat [QBC] analysis) (3). However, these methods
require technical expertise and do not identify Borrelia
species. Another method, culture ex vivo, is difficult to
perform and rarely used in African medical laboratories. In
contrast, the polymerase chain reaction (PCR) is a sensi-
tive diagnostic tool that is widely used in developing coun-
tries in AIDS, malaria, and entomology-related disease
control programs. 
The Study
The objective of our study was to develop a PCR
method to identify the main Borrelia species in uncultured
serum from patients with relapsing fevers in Senegal. This
study was conducted using primers for single nucleotide
polymorphisms (SNPs) in the 16S ribosomal RNA (rrs)
gene of Borrelia sp. Sequencing of the rrs gene has shown
that B. crocidurae, B. duttonii, B. recurrentis, and B. his-
panica belong to the same species cluster (4). B. crocidu-
rae differs from B. duttonii in this gene by only 1 nt (G63A
polymorphism, GenBank accession no. M88329) and from
B. recurrentis by 2 nt (G63A and C211T, GenBank acces-
sion no. M88329) (4). These SNPs have also been identi-
fied in Borrelia species found outside sub-Saharan Africa.
We used this method to analyze blood samples collect-
ed from patients treated at the medical laboratory of the
Institut Pasteur in Dakar, Senegal, for suspected malaria
from October 1999 to October 2003. In addition to routine
laboratory analysis, PCR was performed on frozen serum.
Spirochetes were first detected in fresh blood samples by
microscopic examination with a QBC kit (Makromed,
Johannesburg, South Africa). Five hundred microliters of
serum from spirochete-positive patients was then used for
extraction of DNA. Extraction was performed according to
the method of Wilson (5), with slight modifications. Serum
was diluted in distilled water (final volume 1.5 mL) and
centrifuged at 15,000 rpm for 30 min at 4°C. DNA was
extracted from the pellet by incubation for 2 h at 37°C in
extraction buffer (1mol/LTris, 0.5mol/LEDTA, proteinase
K [20 mg/mL], and 10% sodium dodecyl sulfate), purified
by a standard phenol/chloroform procedure (6), and pre-
cipitated with ethanol. Thermolysates provided by the
National Borrelia Reference Center (CNRB) (Pasteur
Institute, Paris, France) served as controls.
The primers used in this study are listed in the Table.
Borrelia species were first identified by using the nested
PCR reported by Ras et al. (4). It consisted of amplifica-
tion of a 523-bp region of the rrs gene using primers sets
fD3-T50 and Rec4-Rec9. In a second PCR, the presump-
tive identification of the Borrelia species was made using
primer set Fd3-595R for the first amplification and specif-
ic primer sets (BcroF-255R for B. crocidurae, BdutF-255R
for B. duttonii, and BrecF-500R for B. recurrentis) for the
second amplification. These 3 specific primers sets were
used in 3 separate reactions for the second PCR. Species
identification was systematically confirmed by sequencing
the rrs gene. The 3 species-specific primer sets include the
SNPs up to their last 3′ base. Based on the alignment of
sequences of Borrelia found in GenBank, these 3 primer
sets can also hybridize with other sequences from the
Eurasian B. burgdorferi sensu lato group and the North
America relapsing fever group. 
The reaction conditions were adapted to optimize
species-specific amplification by using thermolysates of
strains obtained from CNRL as positive controls. Serum
samples negative for Borrelia and DNA extracted from
Escherichia coli, Plasmodium, Mycoplasma, and Candida
obtained from our medical laboratory were used as nega-
tive controls. 
All PCR amplifications were performed in a final vol-
ume of 25 µL containing approximately 3 ng of DNA, 10
mmol/L Tris-HCl (pH 8.3), 2.5 mmol/L MgCl2, 200
mmol/L of each deoxynucleotide triphosphate, 1 U of Taq
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Francepolymerase (Amersham Biosciences, Piscataway, NJ,
USA), and 1 mmol/L of each primer. Amplification in all
PCRs was carried out for 35 cycles with denaturation at
93°C for 1 min, annealing at 4°C below the melting tem-
perature of the primer (Table) used for 1 min, and exten-
sion at 72°C for 2 min. For PCR species typing, annealing
was performed at 70°C for 40 s and extension at 72°C for
40 s. Final PCR products were detected by electrophoresis
on a 1.5% agarose gel stained with ethidium bromide. PCR
analyses were performed according to Good Laboratory
Practice to avoid cross-contamination between samples
during extraction or amplification. Under the PCR condi-
tions defined, the 3 West African Borrelia species were
amplified only with their respective primers. 
We tested potential cross-amplification of Eurasian and
North American strains by using strains provided by
CNRB. Typical bands were found in the thermolysates of
B. hermsii (strainHS1), B. parkeri (strain M3001), and B.
turicatae (strain 2007) when the specific primer for B. cro-
cidurae was used. The thermolysates of B. duttonii (strain
Ly), B. garinii (strain 20047), and B. burgdorferi sensu
stricto (strain B31) were amplified with the specific primer
for B. duttonii. However, since the geographic distribution
of these pathogens does not overlap, species identification
is relatively simple. For example, B. hispanica and  B.
burgdorferi sensu lato have not been previously found in
sub-Saharan Africa.
Conclusions
Most patients treated at the medical laboratory of the
Institut Pasteur in Dakar, Senegal, during the study period
were residents of the Dakar area. Of the 7,750 patients
included in this study, 3,300 were females and 4,450 were
males; their mean age was 44.5 years. A total of 605
(7.8%) patients tested positive for malaria; most infections
were diagnosed as Plasmodium falciparum. Spirochetes
were found in the blood of 33 patients by microscopic
examination. Only 1 patient was infected with both spiro-
chetes and P. falciparum. In contrast to malaria, detection
of spirochetes does not exhibit a seasonal variation in
prevalence rates. Sera were available for 25 of 33 spiro-
chete-positive patients. Using our species-specific nested
PCR, we found that serum from 25 of these patients con-
tained B. crocidurae. As described earlier, the presence of
this species was confirmed by gene sequencing.
This new nested PCR is an efficient method for identi-
fying tickborne relapsing fevers in sub-Saharan Africa. The
procedures were conducted over a 2-day period with stan-
dard PCR equipment and could also be useful in epidemio-
logic studies. This study also confirmed that B. crocidurae
is the most prevalent Borrelia species in the study area.
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